USANA Health (USNA)
NYSE:USNA
Want to see USNA full AI Analyst Report?
USNA Stock Chart & Stats
$22.53
-$0.56(-1.60%)
At close: 4:00 PM EST
$22.53
-$0.56(-1.60%)
Day’s Range― - ―
52-Week Range$16.60 - $38.32
Previous CloseN/A
Volume19.92K
Average Volume (3M)173.43K
Market Cap
$367.60M
Enterprise Value$189.12M
Total Cash (Recent Filing)$162.75M
Total Debt (Recent Filing)$14.00M
Price to Earnings (P/E)41.3
Beta1.14
Next Earnings
Jul 28, 2026EPS Estimate
0.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.47
Shares Outstanding18,463,010
10 Day Avg. Volume170,208
30 Day Avg. Volume173,431
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)0.68
Price to Sales (P/S)0.39
P/FCF Ratio42.35
Enterprise Value/Market Cap0.51
Enterprise Value/Revenue0.20
Enterprise Value/Gross Profit0.27
Enterprise Value/Ebitda2.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.95
Revenue Forecast (FY)$938.74M
Bulls Say, Bears Say
Bulls Say
High Gross Margins & Improving RevenueSustained ~77% gross margin and resumed TTM revenue growth signal durable product-level economics and pricing power. High gross margin provides structural capacity to absorb SG&A investments, fund R&D and retail expansion, and supports margin recovery as sales scale across channels.
Conservative, Low‑debt Balance SheetExtremely low leverage offers durable financial flexibility to fund omnichannel investments, absorb inventory builds for retail rollouts, and withstand macro volatility without forcing asset sales or dilutive capital raises, supporting long-term strategic optionality.
Omni‑channel & Rise Wellness Retail TractionRapid retail expansion and a fast-growing Rise Wellness line materially diversify distribution beyond direct selling. National retailer placements and an expanding omni-channel mix (>20% target) create durable new revenue channels, lowering reliance on distributor-driven growth and enabling scale benefits.
Bears Say
Weak Cash Generation And Low FCFVery low free cash flow and weak cash conversion reduce the firm's ability to self-fund retail inventory, marketing scale and capex without drawing on reserves or capital markets. Persistent weak cash generation constrains reinvestment and increases sensitivity to execution setbacks.
Elevated HYA Customer Acquisition Costs & Higher SG&AHigher CAC and rising SG&A for the Hiya Health build are structural near-term headwinds. If acquisition economics don't improve or LTVs rise, sustained marketing intensity will compress margins and delay contribution from HYA despite revenue scale, pressuring long-term profitability.
Core Customer Attrition & Stabilization RiskDeclines in active customers and core sales indicate underlying retention challenges in legacy markets. Until customer counts stabilize and reactivation succeeds, top-line recovery depends on offsetting gains from new channels, creating execution risk and uncertainty about sustainable growth.
USANA Health News
USNA FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was $16.60 and its highest was $38.32 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is $367.60M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Jul 28, 2026 which is in 43 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on May 05, 2026. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.17.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.43.
How many shares outstanding does USANA Health have?
USANA Health has 18,463,010 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of $0.61 in its last earnings report, beating expectations of $0.44. Following the earnings report the stock price went up 3.894%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in USNA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
USNA Sentiment 75%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 32.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $489.3K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.01%
12-Months-Change
Fundamentals
Return on Equity
2.03%
Trailing 12-Months
Asset Growth
-0.71%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. specializes in the development, manufacturing, and direct sale of science-based nutritional supplements and personal care products. Its diverse product portfolio includes foundational nutrition, such as the Essentials/CellSentials vitamin and mineral supplements designed to support overall health across various age demographics. Complementing these are targeted optimizers addressing specific needs like cardiovascular, skeletal, or digestive well-being, alongside a range of food items including meal replacement shakes and snack bars. The company's personal care line, Celavive, provides a comprehensive skincare regimen suitable for diverse skin types and ethnic backgrounds. Additionally, USANA offers specialized products catering to prenatal, infant, and young child age groups. To empower its independent associates, USANA provides extensive materials and online resources to facilitate business development and product marketing. Its products are distributed directly to consumers and online across key markets in the Asia Pacific region, the Americas, and Europe. Furthermore, USANA maintains research collaboration agreements with institutions like the Beijing University of Chinese Medicine for traditional Chinese medicine studies and the National Sports Training Bureau. Established in 1992, USANA Health Sciences, Inc. is headquartered in Salt Lake City, Utah.
USNA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed meaningful progress across multiple strategic priorities: sequential recovery in the core nutritional business, strong acceleration and retail traction for Rise Wellness, and international and retail expansion for HYA alongside operational integrations and a sizable R&D pipeline. Near-term pressures include higher customer acquisition costs (HYA), increased SG&A, cash used to support initial retail inventory (Costco), and some uncertainty around retailer cadence and macro risks. On balance, the positive operational momentum, reaffirmed guidance ($925M–$1.0B) and advancing omni-channel mix outweigh the contained near-term costs and risks.View all USNA earnings summariesTechnical Analysis
Ownership Overview
40.86% Insiders
10.42% Mutual Funds
14.15% Other Institutional Investors
23.10% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---